KLK3 and prostate carcinoma: Considering these facts, it appears that factors representing disease progression might be associated with OS in patients with progressive disease, while factors reflecting the patient’s general condition might be correlated with OS in patients with less progressive disease – namely, prostate cancer with low serum PSA level at chemotherapy initiation or without bone metastases and visceral metastases.